Mariner’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.3M Buy
300,755
+56,113
+23% +$6.03M 0.05% 311
2025
Q1
$24.7M Buy
244,642
+68,876
+39% +$6.95M 0.04% 340
2024
Q4
$15.7M Buy
175,766
+11,030
+7% +$985K 0.03% 423
2024
Q3
$13.8M Buy
164,736
+7,693
+5% +$644K 0.02% 447
2024
Q2
$12.1M Buy
157,043
+12,108
+8% +$932K 0.02% 457
2024
Q1
$9.93M Buy
144,935
+16,171
+13% +$1.11M 0.02% 512
2023
Q4
$7.44M Buy
128,764
+2,034
+2% +$118K 0.02% 560
2023
Q3
$6.69M Buy
126,730
+10,214
+9% +$539K 0.02% 556
2023
Q2
$6.3M Buy
116,516
+510
+0.4% +$27.6K 0.02% 572
2023
Q1
$5.8M Buy
116,006
+11,885
+11% +$594K 0.02% 585
2022
Q4
$4.82M Buy
104,121
+6,766
+7% +$313K 0.02% 616
2022
Q3
$3.77M Buy
97,355
+18,864
+24% +$731K 0.02% 591
2022
Q2
$2.93M Buy
78,491
+181
+0.2% +$6.75K 0.01% 610
2022
Q1
$3.47M Buy
78,310
+29,375
+60% +$1.3M 0.01% 578
2021
Q4
$2.08M Buy
48,935
+13,571
+38% +$577K 0.01% 651
2021
Q3
$1.53M Buy
35,364
+3,820
+12% +$166K 0.01% 596
2021
Q2
$1.35M Buy
31,544
+18,025
+133% +$771K 0.01% 588
2021
Q1
$523K Buy
13,519
+1,808
+15% +$69.9K ﹤0.01% 733
2020
Q4
$421K Sell
11,711
-4,090
-26% -$147K ﹤0.01% 700
2020
Q3
$603K Sell
15,801
-1,637
-9% -$62.5K 0.01% 583
2020
Q2
$612K Buy
17,438
+1,470
+9% +$51.6K 0.01% 574
2020
Q1
$521K Buy
15,968
+1,119
+8% +$36.5K 0.01% 577
2019
Q4
$671K Buy
14,849
+2,999
+25% +$136K 0.01% 572
2019
Q3
$482K Buy
11,850
+779
+7% +$31.7K 0.01% 604
2019
Q2
$476K Buy
11,071
+1,115
+11% +$47.9K 0.01% 740
2019
Q1
$382K Buy
9,956
+1,773
+22% +$68K 0.01% 736
2018
Q4
$289K Buy
8,183
+244
+3% +$8.62K 0.01% 674
2018
Q3
$306K Buy
+7,939
New +$306K 0.01% 652